Patient Health Questionnaire 15-item Somatic Symptom Severity Scale (Phq-15) - Pfizer

The Patient Health Questionnaire 15-item Somatic Symptom Severity Scale (PHQ-15) is a tool developed by Pfizer used in the medical field for screening and measuring the severity of somatic symptoms. Somatic symptoms refer to physical symptoms like pain, fatigue, and dizziness that could potentially be linked to mental health issues like anxiety and depression. This tool aids healthcare professionals in identifying and managing these symptoms, guiding treatment strategies, and monitoring the patient's progress over time.

The Patient Health Questionnaire 15-item Somatic Symptom Severity Scale (Phq-15), which is developed by Pfizer, is typically filled out by the patient themselves as it is designed to assess their self-reported symptom severity. The form may be provided and interpreted by healthcare professionals such as doctors, psychiatrists, psychologists, or therapists during a medical consultation or mental health assessment.

FAQ

Q: What is the Patient Health Questionnaire 15-item Somatic Symptom Severity Scale (Phq-15)?
A: The PHQ-15 is a self-administered questionnaire that assesses the severity of various bodily symptoms such as stomach issues, fatigue, and back pain. It has been developed by Pfizer and is often used by doctors for diagnosing somatic symptom disorder.

Q: What is the function of the PHQ-15?
A: The PHQ-15 from Pfizer is used to measure the severity of self-reported somatic symptoms. The questions focus on physical complaints that could potentially indicate underlying mental health difficulties such as anxiety or depression.

Q: Who developed the PHQ-15?
A: The PHQ-15 was developed by the pharmaceutical company Pfizer.

Q: What type of health disorders does the PHQ-15 help detect?
A: PHQ-15 helps to screen and identify somatic symptom disorders, which are mental health disorders characterized by an extreme focus on physical symptoms. It can also sometimes indicate other underlying mental health problems like anxiety and depression.

Q: How is the PHQ-15 administered?
A: The PHQ-15 is a self-administered questionnaire. Patients are asked to rate the severity of their symptoms over the past week on a scale from 0, which means 'not bothered at all', to 2, which means 'bothered a lot'.

Q: What bodily symptoms does the PHQ-15 questionnaire cover?
A: The PHQ-15 questionnaire covers a wide range of bodily symptoms including digestive problems, fatigue, pain, cardiovascular symptoms, respiratory symptoms, dermatological symptoms and more.

Q: Is the PHQ-15 questionnaire reliable?
A: Yes, the PHQ-15 questionnaire is a reliable tool for the measurement of somatic symptom severity in clinical practice and research. However, it should be used in conjunction with a comprehensive clinical evaluation for accurate diagnosis.